Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance

Ironwood Pharma (IRWD) Misses Q1 EPS by 1c; Offers FY23 Revenue Guidance

May 4, 2023 8:20 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of $0.25, $0.01 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $104.06 million versus the consensus estimate of $100.3 million.

GUIDANCE:

Ironwood Pharma sees FY2023 revenue of $420-435 million, versus the consensus of... More